Skip to main content
SpringerLink
Log in

Modeling Tumor–Immune Dynamics

  • Conference paper
  • First Online:
Mathematical Models of Tumor-Immune System Dynamics

Part of the book series: Springer Proceedings in Mathematics & Statistics ((PROMS,volume 107))

Abstract

Mathematical models of tumor–immune interactions provide an analytical framework in which to address specific questions regarding tumor–immune dynamics and tumor treatment options. We present a mathematical model, in the form of a system of ordinary differential equations (ODEs), that governs cancer growth on a cell population level. In addition to a cancer cell population, the model includes a population of Natural Killer (NK) and CD8+ T immune cells. Our goal is to understand the dynamics of immune-mediated tumor rejection, in addition to exploring results of applying combination immune, vaccine and chemotherapy treatments. We characterize the ODE system dynamics by locating equilibrium points, determining stability properties, performing a bifurcation analysis, and identifying basins of attraction. These system characteristics are useful, not only for gaining a broad understanding of the specific system dynamics, but also for helping to guide the development of combination therapies. Additionally, a parameter sensitivity analysis suggests that the model can predict which patients may respond positively to treatment. Numerical simulations of mixed chemo-immuno and vaccine therapy using both mouse and human parameters are presented. Simulations of tumor growth using different levels of immune stimulating ligands, effector cells, and tumor challenge, are able to reproduce data from published studies. We illustrate situations for which neither chemotherapy nor immunotherapy alone are sufficient to control tumor growth, but in combination the therapies are able to eliminate the entire tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Adam, J.A., Bellomo, N.: A Survey of Models for Tumor Immune Systems Dynamics. Springer, New York (1997)

    Book  Google Scholar 

  2. Akçakaya, H., Arditi, R., Ginzburg, L.R.: Ratio-dependent predation: an abstraction that works. Ecology 76, 995–1004 (1995)

    Article  Google Scholar 

  3. Bannock, L.: Nutrition (2002). Found at http://www.doctorbannock.com/nutrition.html. Accessed January 2013

  4. Bellomo, N., Preziosi, L.: Modelling and mathematical problems related to tumor evolution and its interaction with the immune system. Math. Comput. Model. 32(3–4), 413–452 (2000)

    Article  MATH  MathSciNet  Google Scholar 

  5. Blattman, J., Greenberg, P.: Cancer immunotherapy: a treatment for the masses. Science 305, 200–205 (2004)

    Article  Google Scholar 

  6. Borrelli, R., Coleman, C.: Differential Equations: A Modeling Perspective. Wiley, New York (1998)

    MATH  Google Scholar 

  7. Britton, N.: Essential Mathematical Biology. Springer, London (2003)

    Book  MATH  Google Scholar 

  8. Calabresi, P., Schein, P. (eds.).: Medical Oncology: Basic Principles and Clinical Management of Cancer, 2nd edn. McGraw-Hill, New York (1993)

    Google Scholar 

  9. Coldman, A.J., Goldie, J.H.: A stochastic model for the origin and treatment of tumors containing drug-resistant cells. Bull. Math. Biol. 48(3 − 4), 279–292 (1986); Simulation in cancer research (Durham, 1986)

    Google Scholar 

  10. Cooper, M., Fehniger, T., Caligiuri, M.: The biology of human natural killer-cell subsets. Trends Immunol. 22(11), 633–640 (2001)

    Article  Google Scholar 

  11. Couzin, J.: Select T cells, given space, shrink tumors. Science 297, 1973 (2002)

    Article  Google Scholar 

  12. Dalgleish, A.G., O’Byrne, K.J.: Chronic immune activation and inflammation in the pathogenesis of AIDS and cancer. Adv. Cancer Res. 84, 231–276 (2002)

    Article  Google Scholar 

  13. de Pillis, L., Caldwell, T., Sarapata, E., Williams, H.: Mathematical modeling of the regulatory T cell effects on renal cell carcinoma treatment. Discr. Contin. Dyn. Syst. Ser. B 18(4), 915–94 (2013)

    Article  MATH  Google Scholar 

  14. de Pillis, L., Gallegos, A., Radunskaya, A.: A model of dendritic cell therapy for melanoma. Front. Oncol. 3(56), 1–14 (2013). http://www.frontiersin.org/molecular_and_cellular_oncology/10.3389/fonc.2013.00056/abstract. Accessed January 2013

  15. de Pillis, L., Gu, W., Radunskaya, A.: Mixed immunotherapy and chemotherapy of tumors: modeling applications and biological interpretations. J. Theor. Biol. 238(4), 841–862 (2006)

    Article  Google Scholar 

  16. de Pillis, L., Radunskaya, A.: A mathematical tumor model with immune resistance and drug therapy: an optimal control approach. J. Theor. Med. 3, 79–100 (2001)

    Article  MATH  Google Scholar 

  17. de Pillis, L., Radunskaya, A.: Immune response to tumor invasion. In: Bathe, K., (ed.) Computational Fluid and Solid Mechanics, vol. 2, pp. 1661–1668. MIT, Cambridge (2003)

    Google Scholar 

  18. de Pillis, L.G., Radunskaya, A.: The dynamics of an optimally controlled tumor model: a case study. Math. Comput. Model. 37, 1221–1244 (2003)

    Article  MATH  Google Scholar 

  19. de Pillis, L., Radunskaya, A.: Some promising approaches to tumor-immune modeling. Math. Stud. Hum. Dis. Dyn. 410, 89–112 (2006)

    Article  Google Scholar 

  20. de Pillis, L., Radunskaya, A.: Best practices in mathematical modeling. In: Mayeno, A., Reisfeld, B., (eds.) Computational Toxicology, Methods in Molecular Biology, vol. 929, Part 2, pp. 51–74. Springer, New York (2012)

    Google Scholar 

  21. de Pillis, L.G., Radunskaya, A.E., Savage, H.: Mathematical model of colorectal cancer with monoclonal antibody treatments. Br. J. Med. Med. Res. 4(16), 3101–3131 (2014)

    Article  Google Scholar 

  22. de Pillis, L., Radunskaya, A., Wiseman, C.: A validated mathematical model of cell-mediated immune responses to tumor invasion and vaccine therapy in mice and humans. Invited Poster, Society of Biological Therapy 17th Annual Meeting (2003)

    Google Scholar 

  23. de Pillis, L.G., Radunskaya, A.E., Wiseman, C.L.: A validated mathematical model of cell-mediated immune response to tumor growth. Cancer Res. 65(1), 7950–7958 (2005)

    Google Scholar 

  24. Diefenbach, A., Jensen, E., Jamieson, A., Raulet, D.: Rae1 and H60 ligands of the NKG2D receptor stimulate tumor immunity. Nature 413, 165–171 (2001)

    Article  Google Scholar 

  25. Donnelly, J.: Cancer vaccine targets leukemia. Nat. Med. 9(11), 1354–1356 (2003)

    Article  Google Scholar 

  26. Dudley, M., Wunderlich, J., Robbins, P., Yang, J., Hwu, P., Schwartzentruber, D., Topalian, S., Sherry, R., Restifo, N., Hubicki, A., Robinson, M., Raffeld, M., Duray, P., Seipp, C., Rogers-Freezer, L., Morton, K., Mavroukakis, S., White, D., Rosenberg, S.: Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes. Science 298(5594), 850–854 (2002)

    Article  Google Scholar 

  27. Eisen, M.: Mathematical Models in Cell Biology and Cancer Chemotherapy. Springer, Berlin (1979)

    Book  MATH  Google Scholar 

  28. Farrar, J., Katz, K., Windsor, J., Thrush, G., Scheuermann, R., Uhr, J., Street, N.: Cancer dormancy. VII. A regulatory role for CD8+ T cells and IFN-gamma in establishing and maintaining the tumor-dormant state. J. Immunol. 162(5), 2842–9 (1999)

    Google Scholar 

  29. Gardner, S.N.: A mechanistic, predictive model of dose-response curves for cell cycle phase-specific and nonspecific drugs. Cancer Res. 60, 1417–1425 (2000)

    Google Scholar 

  30. Gatenby, R., Vincent, T.: Application of quantitative models from population biology and evolutionary game theory to tumor therapeutic strategies. Mol. Cancer Ther. 2(9), 919–927 (2003)

    Google Scholar 

  31. Germain, R.: An innately interesting decade of research in immunology. Nat. Med. 10(12), 1307–1320 (2004)

    Article  Google Scholar 

  32. Gilks, W.: Markov Chain Monte Carlo. Encyclopedia of Biostatistics. Wiley Online Library, MRC Biostatistics Unit, Cambridge (2005)

    Google Scholar 

  33. Glas, R., Franksson, L., Une, C., Eloranta, M., Ohlen, C., Orn, A., Karre, K.: Recruitment and activation of natural killer (NK) cells in vivo determined by the target cell phenotype: an adaptive component of NK cell-mediated responses. J. Exp. Med. 191(1), 129–138 (2000)

    Article  Google Scholar 

  34. Hadj, T.: Alemtuzumab for B-cell chronic lymphocytic leukemia. Issues Emerg. Health Technol. 66, 1–4 (2005)

    Google Scholar 

  35. Hart, D., Shochat, E., Agur, Z.: The growth law of primary breast cancer as inferred from mammography screening trials data. Br. J. Cancer 78(3), 382–387 (1998)

    Article  Google Scholar 

  36. Hauser, B.: Blood tests. Tech. rep., International Waldenstrom’s Macroglobulinemia Foundation (2001). Available at http://www.iwmf.com/Blood_Tests.pdf. Accessed May 2005

  37. Henderson, D., Jacobson, S., Johnson, A.: The theory and practice of simulated annealing. In: Glover, F., Kochenberger, G., (eds.) Handbook of Metaheuristics, International Series in Operations Research & Management Science, vol. 57, pp. 287–319. Springer US (2003). doi:10.1007/0-306-48056-5_10

  38. Institute, C.R.: Cancer and the immune system: The vital connection. Web page publication of the Cancer Research Institute (2000). http://www.cancerresearch.org. Available at http://www.cancerresearch.org/immunology/immuneindex.html. Accessed May 2005

  39. Jiang, H., Chess, L.: An integrated view of supporessor T cell subsets in immunoregulation. J. Clin. Invest. 114(9), 1198–1208 (2004)

    Article  Google Scholar 

  40. Kawarada, Y., Ganss, R., Garbi, N., Sacher T. ad Arnold, B., Hammerling, G.: NK- and CD8+ T cell-mediate eradication of established tumors by peritumoral injection of CpG-containing oligodeoxynucleotides. J. Immunol. 167(1), 5247–5253 (2001)

    Google Scholar 

  41. Kieper, W., Prlic, M., Schmidt, C., Mescher, M., Jameson, S.: Il-12 enhances CD8+ T cell homeostatic expansion. J. Immunol. 166, 5515–5521 (2001)

    Article  Google Scholar 

  42. Kirschner, D., Panetta, J.: Modeling immunotherapy of the tumor-immune interaction. J. Math. Biol. 37(3), 235–52 (1998)

    Article  MATH  Google Scholar 

  43. Kolmogorov, A.: Sulla teoria di volterral della lotta per l’esistenza. Giornale Istituto Ital. Attuari 7, 74–80 (1936)

    MATH  Google Scholar 

  44. Kuznetsov, V.: Basic models of tumor-immune system interactions—identification, analysis and predictions. In: Adam, J., Bellomo, N., (eds.) A Survey of Models for Tumor-Immune System Dynamics, pp. 237–294. Springer, Berlin (1997)

    Chapter  Google Scholar 

  45. Kuznetsov, V., Makalkin, I.: Bifurcation-analysis of mathematical-model of interactions between cytotoxic lymphocytes and tumor-cells—effect of immunological amplification of tumor-growth and its connection with other phenomena of oncoimmunology. Biofizika 37(6), 1063–70 (1992)

    Google Scholar 

  46. Kuznetsov, V., Makalkin, I., Taylor, M., Perelson, A.: Nonlinear dynamics of immunogenic tumors: Parameter estimation and global bifurcation analysis. Bull. Math. Biol. 56(2), 295–321 (1994)

    Article  MATH  Google Scholar 

  47. Lanzavecchia, A., Sallusto, F.: Dynamics of T-lymphocyte responses: intermediates, effectors, and memory cells. Science 290, 92–97 (2000)

    Article  Google Scholar 

  48. Li, J., Guo, K., Koh, V., Tang, J., Gan, B., Shi, H., Li, H., Zeng, Q.: Generation of PRL-3- and PRL-1-specific monoclonal antibodies as potential diagnostic markers for cancer metastases. Clin. Cancer Res. 11(6), 2195–2204 (2005)

    Article  Google Scholar 

  49. Machiels, J., Reilly, R., Emens, L., Ercolini, A., Lei, R., Weintraub, D., Okoye, F., Jaffee, E.: Cyclophosphamide, doxorubicin, and paclitaxel enhance the antitumor immune response of granulocyte/macrophage-colony stimulating factor-secreting whole-cell vaccines in HER-2/neu tolerized mice. Cancer Res. 61(9), 3689–3697 (2001)

    Google Scholar 

  50. Melichar, B., Dvorak, J., Jandik, P., Touskova, M., Solichova, D., Megancova, J., Z., V.: Intraarterial chemotherapy of malignant melanoma metastatic to the liver. Hepatogastroenterology 48(42), 1711–1715 (2001)

    Google Scholar 

  51. Meyskens, F.J., Thomson, S.P., Moon, T.E.: Quantitation of the number of cells within tumor colonies in semisolid medium and their growth as oblate spheroids. Cancer Res. 44, 271–277 (1984)

    Google Scholar 

  52. Morecki, S., Pugatsch, T., Levi, S., Moshel, Y., Slavin, S.: Tumor-cell vaccination induces tumor dormancy in a murine model of B-cell leukemia/lymphoma (BCL1). Int. J. Cancer 65(2), 204–8 (1996)

    Article  Google Scholar 

  53. Muller, M., Gounari, F., Prifti, S., Hacker, H., Schirrmacher, V., Khazaie, K.: EblacZ tumor dormancy in bone marrow and lymph nodes: active control of proliferating tumor cells by CD8+ immune T cells. Cancer Res. 58(23), 5439–46 (1998)

    Google Scholar 

  54. Murphy, K.: Janeway’s Immunobiology, 8th edn. Garland Science, New York (2011)

    Google Scholar 

  55. Murray, J.M.: Mathematical Biology, 2nd edn. Springer, Berlin (1993)

    Book  MATH  Google Scholar 

  56. Mustafa, M., Buchanan, G., Winick, N., McCracken, G., Tkaczewski, I., Lipscomb, M., Ansari, Q., Agopian, M.: Immune recovery in children with malignancy after cessation of chemotherapy. J. Pediatr. Hematol. Oncol. 20(5), 451–457 (1998)

    Article  Google Scholar 

  57. O’Byrne, K.J., Dalgleish, A.G., Browning, M.J., Steward, W.P., Harris, A.L.: The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur. J. Cancer 36, 151–169 (2000)

    Article  Google Scholar 

  58. Osada, T., Nagawa, H., Shibata, Y.: Tumor-infiltrating effector cells of α-galactosylceramide-induced antitumor immunity in metastatic liver tumor. J. Immune Based Ther. Vaccines 2(7), 1–9 (2004)

    Google Scholar 

  59. Pardoll, D.: Cancer vaccines. Nat. Med. 4(5), 525–531 (1998) (Vaccine Supplement)

    Google Scholar 

  60. Pazdur, R., Hoskins, W., Wagman, L., Coia, L. (eds.): Cancer Management: A Mulitdisciplinary Approach, 8th edn., chap. Principles of Chemotherapy. Oncology Publishing Group of CMP Healthcare Media (2004). Available at http://www.cancernetwork.com/handbook/contents.htm. Accessed May 2005

  61. Perry, M. (ed.): The Chemotherapy Source Book, 3rd edn. Lippincott Williams & Wilkins, Philadelphia (2001)

    Google Scholar 

  62. Qu, Z., Griffiths, G., Wegener, W., Chang, C., S.V., G., Horak, I., Hansen, H., Goldenberg, D.: Development of humanized antibodies as cancer therapeutics. Methods 36(1), 84–95 (2005). doi:10.1016/j.ymeth.2005.01.008

  63. Roitt, I., Brostoff, J., Male, D.: Immunology. Mosby, St. Louis (1993)

    Google Scholar 

  64. Rosenbaum, E., Rosenbaum, I.: Everyone’s Guide to Cancer Supportive Care: A Comprehensive Handbook for Patients and Their Families. Andrews McMeel, Kansas (2005)

    Google Scholar 

  65. Rosenberg, S., Yang, J., Restifo, N.: Cancer immunotherapy: moving beyond current vaccines. Nat. Med. 10(9), 909–915 (2004)

    Article  Google Scholar 

  66. Sarapata, E., de Pillis, L.: A comparison and catalog of intrinsic tumor growth models. arXiv:1312.4857v1 [q-bio.CB] pp. 1–73 (2013). Preprint, http://arxiv.org/abs/1312.4857

  67. Sen, M.K., Stoffa, P.L.: Global Optimization Methods in Geophysical Inversion. Cambridge University Press, Cambridge (2013)

    Book  Google Scholar 

  68. Skipper, H.E.: On mathematical modeling of critical variables in cancer treatment (goals: better understanding of the past and better planning in the future). Bull. Math. Biol. 48(3–4), 253–278 (1986); Simulation in cancer research (Durham, 1986)

    Google Scholar 

  69. Stewart, T.: Immune mechanisms and tumor dormancy. Medicina (Buenos Aire) 56(1), 74–82 (1996)

    Google Scholar 

  70. The MathWorks, I.: Matlab (2012b)

    Google Scholar 

  71. Volterra, V.: Variazioni e fluttuazioni del numero d’individui in specie animali conviventi. Mem. Acad. Lincei Roma 2, 31–113 (1926)

    Google Scholar 

  72. Wheeler, C., Asha, D., Gentao, L., Yu, J., Black, K.: Clinical responsiveness of glioblastoma multiforme to chemotherapy after vaccination. Clin. Cancer Res. 10, 5316–5326 (2004)

    Article  Google Scholar 

  73. Yates, A., Callard, R.: Cell death and the maintenance of immunological memory. Discr. Contin. Dyn. Ser. B 1(1), 43–59 (2002)

    MathSciNet  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Mathematics, Harvey Mudd College, Claremont, CA, USA

    Lisette G. de Pillis

  2. Department of Mathematics, Pomona College, Claremont, CA, USA

    Ami E. Radunskaya

Authors
  1. Lisette G. de Pillis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ami E. Radunskaya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lisette G. de Pillis .

Editor information

Editors and Affiliations

  1. Mathematics Department, The College of Saint Rose, Albany, New York, USA

    Amina Eladdadi

  2. School of Mathematics and Statistics, University of Sydney, Sydney, New South Wales, Australia

    Peter Kim

  3. Mathematical Sciences School, Queensland University of Technology, Brisbane, Queensland, Australia

    Dann Mallet

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this paper

Cite this paper

de Pillis, L.G., Radunskaya, A.E. (2014). Modeling Tumor–Immune Dynamics. In: Eladdadi, A., Kim, P., Mallet, D. (eds) Mathematical Models of Tumor-Immune System Dynamics. Springer Proceedings in Mathematics & Statistics, vol 107. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1793-8_4

Download citation

Publish with us

Policies and ethics

Search

Navigation